News | October 13, 2021
PCI Pharma Services acquires LSNE for its CDMO business
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Cipla is a leading global pharma company
The consideration for the medicines in India is valued at Rs 180.48 crore
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
It is the first branded generic alternative to Fostair 100/6 pMDI
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Subscribe To Our Newsletter & Stay Updated
